263 related articles for article (PubMed ID: 20306832)
1. Neuroendocrine differentiation in breast cancer: established facts and unresolved problems.
Righi L; Sapino A; Marchiò C; Papotti M; Bussolati G
Semin Diagn Pathol; 2010 Feb; 27(1):69-76. PubMed ID: 20306832
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine Tumors of the Breast.
Rosen LE; Gattuso P
Arch Pathol Lab Med; 2017 Nov; 141(11):1577-1581. PubMed ID: 29072945
[TBL] [Abstract][Full Text] [Related]
3. Histopathological and Clinical Differences Between Primary Breast Carcinomas With Neuroendocrine Features and Primary Breast Carcinomas Mimicking Neuroendocrine Features.
Kelten Talu C; Savli TC; Huq GE; Leblebici C
Int J Surg Pathol; 2019 Oct; 27(7):744-752. PubMed ID: 31195855
[TBL] [Abstract][Full Text] [Related]
4. [Neuroendocrine carcinoma of breast: a study of tumor morphology and subtyping].
Gao LX; Liu G; Li L; Lin HY; Jin H; Cheng J; Jin ML; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):604-9. PubMed ID: 22177244
[TBL] [Abstract][Full Text] [Related]
5. Primary breast carcinomas with neuroendocrine features: Clinicopathological features and analysis of tumor growth patterns in 36 cases.
Kelten Talu C; Leblebici C; Kilicaslan Ozturk T; Hacihasanoglu E; Baykal Koca S; Gucin Z
Ann Diagn Pathol; 2018 Jun; 34():122-130. PubMed ID: 29661717
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome.
Bogina G; Munari E; Brunelli M; Bortesi L; Marconi M; Sommaggio M; Lunardi G; Gori S; Massocco A; Pegoraro MC; Zamboni G
Histopathology; 2016 Feb; 68(3):422-32. PubMed ID: 26114478
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine breast carcinoma: a rare but challenging entity.
Trevisi E; La Salvia A; Daniele L; Brizzi MP; De Rosa G; Scagliotti GV; Di Maio M
Med Oncol; 2020 Jul; 37(8):70. PubMed ID: 32712767
[TBL] [Abstract][Full Text] [Related]
8. Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type.
Weigelt B; Geyer FC; Horlings HM; Kreike B; Halfwerk H; Reis-Filho JS
Mod Pathol; 2009 Nov; 22(11):1401-14. PubMed ID: 19633645
[TBL] [Abstract][Full Text] [Related]
9. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
[TBL] [Abstract][Full Text] [Related]
10. A case of multicentric low-grade neuroendocrine breast tumor with an unusual histological pattern.
D'Antonio A; Addesso M; Memoli D; Cascone A; Cremone L
Breast Dis; 2016; 36(4):161-164. PubMed ID: 27802189
[TBL] [Abstract][Full Text] [Related]
11. Expression of neuroendocrine markers in different molecular subtypes of breast carcinoma.
Wachter DL; Hartmann A; Beckmann MW; Fasching PA; Hein A; Bayer CM; Agaimy A
Biomed Res Int; 2014; 2014():408459. PubMed ID: 24701575
[TBL] [Abstract][Full Text] [Related]
12. Mucinous carcinoma of the breast: a comparative study on cytohistological findings associated with neuroendocrine differentiation.
Ohashi R; Sakatani T; Matsubara M; Watarai Y; Yanagihara K; Yamashita K; Tsuchiya S; Takei H; Naito Z
Cytopathology; 2016 Jun; 27(3):193-200. PubMed ID: 26804749
[TBL] [Abstract][Full Text] [Related]
13. Papillary and neuroendocrine breast lesions: the WHO stance.
Tan PH; Schnitt SJ; van de Vijver MJ; Ellis IO; Lakhani SR
Histopathology; 2015 May; 66(6):761-70. PubMed ID: 24845113
[TBL] [Abstract][Full Text] [Related]
14. The genetic landscape of breast carcinomas with neuroendocrine differentiation.
Marchiò C; Geyer FC; Ng CK; Piscuoglio S; De Filippo MR; Cupo M; Schultheis AM; Lim RS; Burke KA; Guerini-Rocco E; Papotti M; Norton L; Sapino A; Weigelt B; Reis-Filho JS
J Pathol; 2017 Feb; 241(3):405-419. PubMed ID: 27925203
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters.
Tse GM; Ma TK; Chu WC; Lam WW; Poon CS; Chan WC
Mod Pathol; 2004 May; 17(5):568-72. PubMed ID: 15001999
[TBL] [Abstract][Full Text] [Related]
16. Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges.
Tang F; Wei B; Tian Z; Gilcrease MZ; Huo L; Albarracin CT; Resetkova E; Zhang H; Sahin A; Chen J; Bu H; Abraham S; Wu Y
Histopathology; 2011 Jul; 59(1):106-15. PubMed ID: 21668471
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine Breast Carcinomas Share Prognostic Factors with Gastroenteropancreatic Neuroendocrine Tumors: A Putative Prognostic Role of Menin, p27, and SSTR-2A.
Roininen N; Takala S; Haapasaari KM; Jukkola-Vuorinen A; Mattson J; Heikkilä P; Karihtala P
Oncology; 2019; 96(3):147-155. PubMed ID: 30282082
[TBL] [Abstract][Full Text] [Related]
18. Double neuroendocrine ductal carcinomas in situ coexisting with a background of diffuse idiopathic neuroendocrine cell hyperplasia of breast: a case report and hypothesis of neuroendocrine tumor development.
Miura K; Nasu H; Ogura H
Pathol Int; 2012 May; 62(5):331-4. PubMed ID: 22524661
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine carcinomas of the breast.
Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
[TBL] [Abstract][Full Text] [Related]
20. [Breast carcinoma with predominant neuroendocrine differentiation].
Frachon S; Pasquier D; Treilleux I; Seigneurin D; Ringeisen F; Rosier P; Bolla M; Boutonnat J
Ann Pathol; 2004 Jun; 24(3):278-83. PubMed ID: 15480266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]